Another study found that BRCA2 mutation is more frequent in ESCC patients with FH than in those without FH, suggesting that BRCA2 may play a role in genetic susceptibility to familial ESCC (24). The gene discussed is BRCA2; the disease is familial hyperaldosteronism.